Trastuzumab Recruiting Phase 1 / 2 Trials for Cancer, Breast Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Recruiting | Treatment | 1 / 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT01969643 | A Safety Study of SGN-LIV1A in Breast Cancer Patients | |
| NCT03135171 | Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to Trastuzumab |